We observed a significantly shorter overall survival for patients with lung cancer with PTHrP mRNA levels above the median value (hazard ratio = 1.25 [1.1–1.42], logrank P = 0.00048, n = 2,437; Fig. 3B). This evidence concerns the gene PTHLH and lung carcinoma.